Shifeng Su
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Reproductive Medicine top 10%
- Sperm and Testicular Function
Papers in
-
- Renal and related cancers 5
- Ubiquitin and proteasome pathways 3
- Circular RNAs in diseases 3
-
- Prostate Cancer Treatment and Research 5
- Co-authors
- Aiming Xu (14 shared papers)Gail Grossman (7 shared papers)Zengjun Wang (13 shared papers)John T. Minges (7 shared papers)Elizabeth M. Wilson (6 shared papers)Jianzhong Zhang (9 shared papers)Chenkui Miao (8 shared papers)Jundong Zhu (8 shared papers)
- Journals
- Oncotarget (5 papers)Journal of Biological Chemistry (4 papers)Land Degradation and Development (2 papers)PLoS ONE (2 papers)Tumor Biology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shifeng Su
37 papers receiving 571 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 110
- Reproductive Medicine 52
- Immunology 127
- Molecular Biology 288
- Oncology 90
Countries citing papers authored by Shifeng Su
This map shows the geographic impact of Shifeng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shifeng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shifeng Su more than expected).
Fields of papers citing papers by Shifeng Su
This network shows the impact of papers produced by Shifeng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shifeng Su. The network helps show where Shifeng Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Shifeng Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 42 | |
| 2 | 2017 | 39 | |
| 3 | 2018 | 38 | |
| 4 | 2013 | 34 | |
| 5 | 2012 | 33 | |
| 6 | 2016 | 33 | |
| 7 | 2012 | 29 | |
| 8 | 2021 | 27 | |
| 9 | 2017 | 25 | |
| 10 | 2023 | 22 | |
| 11 | 2015 | 21 | |
| 12 | 2016 | 21 | |
| 13 | 2017 | 18 | |
| 14 | 2013 | 17 | |
| 15 | 2016 | 17 | |
| 16 | 2022 | 16 | |
| 17 | 2022 | 16 | |
| 18 | 2010 | 15 | |
| 19 | 2016 | 14 | |
| 20 | 2011 | 13 |
About Shifeng Su
Shifeng Su is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Oncology and Reproductive Medicine, having authored 38 papers that have together received 579 indexed citations. Recurring topics across this work include Sperm and Testicular Function (5 papers), Renal and related cancers (5 papers), Prostate Cancer Treatment and Research (5 papers), Immunotherapy and Immune Responses (5 papers), Ubiquitin and proteasome pathways (3 papers), Circular RNAs in diseases (3 papers), Cancer-related Molecular Pathways (3 papers) and Soil Carbon and Nitrogen Dynamics (3 papers). The work is most often cited by research in Cancer Research (110 citations), Reproductive Medicine (52 citations), Immunology (127 citations), Molecular Biology (288 citations) and Oncology (90 citations). Shifeng Su has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Aiming Xu, Gail Grossman, Zengjun Wang, John T. Minges, Elizabeth M. Wilson, Jianzhong Zhang, Chenkui Miao, Jundong Zhu, Zengjun Wang and Bianjiang Liu. Their work appears in journals such as Oncotarget, Journal of Biological Chemistry, Land Degradation and Development, PLoS ONE and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.